{"entity":{"type":"insider","cik":"0001298522","url":"/insider/0001298522","json_url":"/insider/0001298522.json","name":"Bronfeld Zeev","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2007-05-04","last":"2014-08-15","span_basis":"filed_date"},"name_variants":[{"name":"Bronfeld Zeev","source":"filing","n_filings":5,"first_seen":"2007-05-04","last_seen":"2014-08-15"}],"transactions":[{"id":6513118,"accession":"0001144204-14-050791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-050791","line_url":"/filing/0001144204-14-050791#line-1","is_derivative":false,"issuer_cik":"0001006281","issuer_name":"Protalix BioTherapeutics, Inc.","issuer_ticker":"PLX","issuer_name_source":null,"issuer_url":"/issuer/0001006281","owner_cik":"0001298522","owner_name":"Bronfeld Zeev","owner_display_name":"Bronfeld Zeev","owner_url":"/insider/0001298522","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4400000.0,"shares_display":"4,400,000","price_per_share":2.47,"price_display":"2.47","price_state":"stated","total_value":10868000.0,"total_display":"10,868,000.00","total_whole":"10,868,000","shares_owned_after":10066319.0,"shares_owned_after_display":"10,066,319","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-13","filed_date":"2014-08-15","scope":"insider"},{"id":9236042,"accession":"0001144204-11-056641","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-056641","line_url":"/filing/0001144204-11-056641#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP.OB","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001298522","owner_name":"Bronfeld Zeev","owner_display_name":"Bronfeld Zeev","owner_url":"/insider/0001298522","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350000.0,"shares_display":"350,000","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":98000.0,"total_display":"98,000.00","total_whole":"98,000","shares_owned_after":5808517.0,"shares_owned_after_display":"5,808,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-27","filed_date":"2011-10-05","scope":"insider"},{"id":9130450,"accession":"0001144204-11-055269","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-055269","line_url":"/filing/0001144204-11-055269#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP.OB","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001298522","owner_name":"Bronfeld Zeev","owner_display_name":"Bronfeld Zeev","owner_url":"/insider/0001298522","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350000.0,"shares_display":"350,000","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":98000.0,"total_display":"98,000.00","total_whole":"98,000","shares_owned_after":5808517.0,"shares_owned_after_display":"5,808,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-27","filed_date":"2011-09-28","scope":"insider"},{"id":9059180,"accession":"0001144204-11-019944","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-019944","line_url":"/filing/0001144204-11-019944#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP.OB","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001298522","owner_name":"Bronfeld Zeev","owner_display_name":"Bronfeld Zeev","owner_url":"/insider/0001298522","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":781250.0,"shares_display":"781,250","price_per_share":0.32,"price_display":"0.32","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":7213205.0,"shares_owned_after_display":"7,213,205","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-31","filed_date":"2011-04-04","scope":"insider"},{"id":6961390,"accession":"0001085037-07-001009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001085037-07-001009","line_url":"/filing/0001085037-07-001009#line-1","is_derivative":false,"issuer_cik":"0001090967","issuer_name":"GLOBAL ENERGY INC","issuer_ticker":"GEYI","issuer_name_source":null,"issuer_url":"/issuer/0001090967","owner_cik":"0001298522","owner_name":"Bronfeld Zeev","owner_display_name":"Bronfeld Zeev","owner_url":"/insider/0001298522","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"common shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000000.0,"shares_display":"30,000,000","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":42000000.0,"shares_owned_after_display":"42,000,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-30","filed_date":"2007-05-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001006281","name":"Protalix BioTherapeutics, Inc.","url":"/issuer/0001006281","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2014-08-15","last_seen":"2014-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001176309","name":"ORAMED PHARMACEUTICALS INC.","url":"/issuer/0001176309","role":"Ten percent owner","n_filings":3,"first_seen":"2011-04-04","last_seen":"2011-10-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001090967","name":"GLOBAL ENERGY INC","url":"/issuer/0001090967","role":"Ten percent owner","n_filings":1,"first_seen":"2007-05-04","last_seen":"2007-05-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001298522","retrieved_at":"2026-08-24T04:52:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}